SEC Form 4 · accession 0001127602-16-046385
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul A Mahon
Officer — EVP & General Counsel
Period of report
Mar 15, 2016
Accepted (ET)
Mar 15, 2016 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 35,221 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $120.26 | Mar 15, 2016 | A | 122,500 | A | Mar 15, 2017 | Mar 15, 2026 | Common Stock | 122,500 | 122,500 | D |
Explanation of responses
- F1Includes 167 shares acquired under the United Therapeutics Corporation Employee Stock Purchase Plan on March 4, 2016.
- F2These stock options vest in one-fourth increments on each of March 15, 2017, 2018, 2019 and 2020.